Tsoukas, M.A. 2023. Glucagon-like Peptide-1 Receptor Agonist Treatment in Type 1 Diabetes: A Review of Current Evidence and Rationale for Use. Canadian Diabetes & Endocrinology Today. 1, 3 (Oct. 2023), 21–26. DOI:https://doi.org/10.58931/cdet.2023.1318.